Burkhart Erin — SEC insider filings
SEC reporting owner CIK 1927648. 14 insider filings on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2022-05-18 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 7,425 shares, $560,449 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 2,286 shares @ $90.00 ($205,740) in BIOMARIN PHARMACEUTICAL INC, filed 2024-04-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | 11 | — | 5 legs · 7,425 sh · $560,449 | 13 |
| GILEAD SCIENCES, INC. (GILD) | SVP, Controllership | 3 | — | — | 6 |
Insider filings — Burkhart Erin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 2,223 · Tax withholding (F): 768 @ $152.67 · Option exercise (M): 2,223 (derivative) | EDGAR |
| 2026-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 2,355 (derivative) · Grant/award (A): 5,455 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 8,890 (derivative) | EDGAR |
| 2025-05-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 996 @ $59.27 · Sale (S): 1,786 @ $59.31 | EDGAR |
| 2025-03-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 1,295 @ $71.52 | EDGAR |
| 2025-03-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 823 @ $69.44 · Grant/award (A): 5,970 @ $0 · Grant/award (A): 9,230 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 1,344 @ $68.38 | EDGAR |
| 2024-08-15 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 714 @ $90 | EDGAR |
| 2024-05-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 993 @ $76.97 | EDGAR |
| 2024-04-12 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 2,286 @ $90 | EDGAR |
| 2024-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 4,720 @ $0 · Tax withholding (F): 372 @ $83.87 · Grant/award (A): 7,050 (derivative) @ $0 | EDGAR |
| 2023-05-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 796 @ $92.02 | EDGAR |
| 2023-03-17 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 3,760 @ $0 · Grant/award (A): 5,720 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 11,130 @ $0 · Grant/award (A): 17,490 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1927648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs